170 related articles for article (PubMed ID: 18720217)
1. In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
Shalit I; Shadkchan Y; Mircus G; Osherov N
Med Mycol; 2009; 47(5):457-62. PubMed ID: 18720217
[TBL] [Abstract][Full Text] [Related]
2. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
3. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
[TBL] [Abstract][Full Text] [Related]
4. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
Yekutiel A; Shalit I; Shadkchan Y; Osherov N
Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
[TBL] [Abstract][Full Text] [Related]
6. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
[TBL] [Abstract][Full Text] [Related]
7. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
Ozdemir HG; Oz Y; Ilkit M; Kiraz N
Med Mycol; 2012 Feb; 50(2):130-5. PubMed ID: 21599550
[TBL] [Abstract][Full Text] [Related]
9. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
[TBL] [Abstract][Full Text] [Related]
10. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
[TBL] [Abstract][Full Text] [Related]
11. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
Castanheira M; Duncanson FP; Diekema DJ; Guarro J; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2012 Jan; 56(1):352-7. PubMed ID: 22083469
[TBL] [Abstract][Full Text] [Related]
12. Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
Oz Y; Dag I; Kiraz N
Mycopathologia; 2012 Jan; 173(1):27-34. PubMed ID: 21842180
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
Kiraz N; Oz Y; Dag I
Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH
Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Schemuth H; Dittmer S; Lackner M; Sedlacek L; Hamprecht A; Steinmann E; Buer J; Rath PM; Steinmann J
Mycoses; 2013 May; 56(3):297-303. PubMed ID: 23170818
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
18. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
Meletiadis J; Stergiopoulou T; O'Shaughnessy EM; Peter J; Walsh TJ
Antimicrob Agents Chemother; 2007 Jun; 51(6):2053-64. PubMed ID: 17387150
[TBL] [Abstract][Full Text] [Related]
19. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
[TBL] [Abstract][Full Text] [Related]
20. Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
Chaturvedi V; Ramani R; Ghannoum MA; Killian SB; Holliday N; Knapp C; Ostrosky-Zeichner L; Messer SA; Pfaller MA; Iqbal NJ; Arthington-Skaggs BA; Vazquez JA; Sein T; Rex JH; Walsh TJ
Antimicrob Agents Chemother; 2008 Apr; 52(4):1500-2. PubMed ID: 18227180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]